Cited by 282

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300

Zimmermann, Holger, Degenkolbe, Roland, Bernard, Hans-Ulrich, O’Connor, Mark J.·1999·Journal of Virology

Abstract

The transforming proteins of the small DNA tumor viruses, simian virus 40 (SV40), adenovirus, and human papillomavirus (HPV) target a number of identical cellular regulators whose functional abrogation is required for transformation. However, while both adenovirus E1A and SV40 large T transforming properties also depend on the targeting of the transcriptional coactivator CBP/p300, no such interaction has been described for the HPV oncoprotein E6 or E7. Here, we demonstrate that the HPV-16 E6 protein, previously shown to facilitate the degradation of p53 in a complex with E6-associated protein (E6AP), also targets CBP/p300 in an interaction involving the C-terminal zinc finger of E6 and CBP residues 1808 to 1826. Furthermore, this interaction is limited to E6 proteins of high-risk HPVs associated with cervical cancer that have the capacity to repress p53-dependent transcription. An HPV-16 E6 mutant (L50G) that binds CBP/p300, but not E6AP, is still capable of down-regulating p53 transcriptional activity. Thus, HPV E6 proteins possess two distinct mechanisms by which to abrogate p53 function: the repression of p53 transcriptional activity by targeting the p53 coactivator CBP/p300, and the removal of cellular p53 protein through the proteosome degradation pathway.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.73.8.6209-6219.1999

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 80

  1. 10.1038/24190 · DOI
  2. 10.1016/S0092-8674(00)80304-9 · DOI
  3. 10.1016/0092-8674(90)90112-R · DOI
  4. 10.1002/j.1460-2075.1995.tb00157.x · DOI
  5. 10.1038/384641a0 · DOI
  6. 10.1128/jvi.63.3.1404-1407.1989 · DOI · Paper page
  7. 10.1128/jvi.65.1.292-298.1991 · DOI · Paper page
  8. 10.1093/jnci/87.11.796 · DOI
  9. 10.1073/pnas.89.10.4549 · DOI
  10. 10.1126/science.7624774 · DOI · Paper page
  11. Crook T. Fisher C. Masterson P. J. Vousden K. H. Modulation of transcriptional regulatory properties of p53 by HPV E6.Oncogene 9 1994 1225 1230
  12. 10.1016/0092-8674(91)90529-8 · DOI
  13. 10.1016/0092-8674(88)90559-4 · DOI · Paper page
  14. 10.1128/MCB.15.8.4215 · DOI
  15. Dyson N. Harlow E. Adenovirus E1A targets key regulators of cell proliferation.Cancer Surv. 12 1992 161 195
  16. 10.1128/MCB.16.7.3454 · DOI
  17. 10.1128/jvi.68.9.5698-5705.1994 · DOI · Paper page
  18. 10.1101/gad.11.16.2090 · DOI · Paper page
  19. 10.1016/S0168-9525(98)01438-3 · DOI
  20. Grossman S. R. Laimins L. A. E6 protein of human papillomavirus type 18 binds zinc.Oncogene 4 1989 1089 1093
  21. 10.1016/S0092-8674(00)80521-8 · DOI · Paper page
  22. 10.1038/42972 · DOI
  23. 10.1101/gad.8.11.1300 · DOI
  24. Howley P. M. Munger K. Romanczuk H. Scheffner M. Huibregtse J. M. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.Proc. Princess Takamatsu Symp. 22 1991 239 248
  25. 10.1101/SQB.1991.056.01.019 · DOI
  26. 10.1038/383022a0 · DOI · Paper page
  27. 10.1016/S0960-9822(02)00636-X · DOI
  28. 10.1101/gad.11.16.2101 · DOI · Paper page
  29. 10.1073/pnas.90.9.3988 · DOI
  30. 10.1002/j.1460-2075.1995.tb07356.x · DOI
  31. 10.1073/pnas.94.21.11612 · DOI · Paper page
  32. 10.1038/380079a0 · DOI · Paper page
  33. 10.1016/S0966-842X(98)01267-0 · DOI
  34. 10.1126/science.279.5351.700 · DOI
  35. 10.1038/278261a0 · DOI
  36. 10.1098/rspb.1985.0077 · DOI
  37. 10.1128/jvi.68.7.4262-4273.1994 · DOI · Paper page
  38. 10.1002/j.1460-2075.1992.tb05375.x · DOI
  39. 10.1101/gad.9.10.1188 · DOI
  40. 10.1073/pnas.94.13.6670 · DOI · Paper page
  41. 10.1038/42981 · DOI
  42. 10.1016/0092-8674(79)90293-9 · DOI
  43. 10.1038/374085a0 · DOI
  44. 10.1128/MCB.17.3.1129 · DOI
  45. 10.1002/j.1460-2075.1992.tb05608.x · DOI
  46. 10.1016/S0959-437X(05)80342-9 · DOI
  47. 10.1002/j.1460-2075.1989.tb08594.x · DOI · Paper page
  48. 10.1128/jvi.65.7.3943-3948.1991 · DOI
  49. 10.1006/viro.1995.1511 · DOI
  50. 10.1016/S0092-8674(00)80376-1 · DOI
  51. 10.1006/viro.1995.1053 · DOI
  52. 10.1128/jvi.70.10.6529-6539.1996 · DOI
  53. 10.1128/JVI.73.5.3574-3581.1999 · DOI
  54. 10.1016/S0092-8674(00)82001-2 · DOI · Paper page
  55. 10.1101/gad.8.11.1285 · DOI
  56. 10.1038/sj.onc.1201202 · DOI
  57. 10.1016/S1097-2765(00)80005-2 · DOI
  58. 10.1101/gad.12.13.2061 · DOI · Paper page
  59. 10.1128/JVI.72.11.8510-8516.1998 · DOI
  60. 10.1016/0092-8674(82)90356-7 · DOI
  61. 10.1016/0092-8674(93)90384-3 · DOI · Paper page
  62. 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  63. 10.1038/sj.onc.1201002 · DOI
  64. 10.1073/pnas.95.5.2290 · DOI
  65. 10.1038/sj.onc.1201540 · DOI
  66. 10.1074/jbc.273.11.6439 · DOI
  67. 10.1038/sj.onc.1202223 · DOI · Paper page
  68. Thomas M. Massimi P. Banks L. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.Oncogene 13 1996 471 480
  69. Thomas M. Massimi P. Jenkins J. Banks L. HPV-18 E6 mediated inhibition of p53 DNA binding activity is independent of E6 induced degradation.Oncogene 10 1995 261 268
  70. 10.1038/sj.onc.1201495 · DOI
  71. 10.1073/pnas.94.9.4412 · DOI
  72. Van Dyke T. A. Analysis of viral-host protein interactions and tumorigenesis in transgenic mice.Semin. Cancer Biol. 5 1994 47 60
  73. 10.1006/scbi.1995.0014 · DOI
  74. 10.1016/0966-842X(96)30024-3 · DOI
  75. 10.1126/science.2157286 · DOI · Paper page
  76. 10.1038/334124a0 · DOI · Paper page
  77. 10.1128/mcb.11.4.2116-2124.1991 · DOI
  78. 10.1128/mcb.11.11.5389-5397.1991 · DOI
  79. 10.1038/382319a0 · DOI
  80. 10.1016/0042-6822(91)90816-T · DOI

Cited by

Metadata

Authors
Zimmermann, H., Degenkolbe, R., Bernard, H.-U., & O’Connor, M. J.
Affiliations
<!--label omitted: 1-->Institute of Molecular and Cell Biology, Singapore 117 609, Singapore
Venue
Journal of Virology
Published
1999-08
Volume
73
Issue
8
Pages
6209-6219
ISSN
  • 0022-538X
  • 1098-5514
Cited by
282
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review